Boehringer Ingelheim, a
Top 20 global pharmaceutical company has selected Veeva CRM, including iRep for
the iPad, for global deployment supporting its prescription medicine commercial
and medical teams. Boehringer Ingelheim is headquartered in Germany,
and operates globally with 145 affiliates and more than 42,000 employees. Over
13,500 users in 60 markets worldwide will go live on Veeva's cloud-based
solution over the next two years; 650 users in Russia
are already live on Veeva CRM. Boehringer Ingelheim executives conducted a
thorough review of the major CRM providers, narrowing it down to three, followed
by a three-month pilot of two solutions before locking on Veeva CRM.
Prior to making the
switch, Boehringer Ingelheim had been using a CRM system built on a
client/server platform. Boehringer Ingelheim wanted a flexible,
industry-specific solution that would not require expensive customization for use by its teams who work
with customers around the world.
"Veeva proved throughout
the pilot that they not only had the better solution but also had the people in
place globally to support Boehringer Ingelheim's changing business. Veeva will
enable our company to successfully apply the philosophy of CRM and not just the
tool," said Andrew Fuchs, Head of Global CRM Program at Boehringer Ingelheim.
Built on an inherently
flexible, multitenant cloud-based platform, Veeva CRM enables life sciences
companies to make changes with simple point-and-click configuration while also
providing ongoing updates transparently that customers can "turn on or off" as
needed. The complete suite delivers rich functionality that supports
the unique needs of various commercial teams in a single solution - precisely
what Boehringer Ingelheim executives were searching for in a global CRM
solution. Veeva CRM also empowers customers with advanced
reporting capabilities as well as anytime, anywhere access with
iRep. iRep has quickly become the industry's choice
for comprehensive CRM and CLM on the iPad with the largest installed
base worldwide, according to recent numbers.
Boehringer Ingelheim
expects that Veeva CRM will:
- Decrease
complexity (application, maintenance, change process) to significantly
reduce costs;
- Create
a global CRM capability framework to drive global synergies;
- Establish
a flexible technology platform that can quickly adjust to changing
business needs as well as market-specific (local/regional) requirements;
- Improve
salesforce effectiveness.
"Veeva will provide
Boehringer Ingelheim with a flexible, cost effective, global CRM platform to
better enable our customer-facing organizations, reduce development costs and
allow our Information Systems group to rapidly adapt to changing customer needs,"
added Scott Morrison, vice president, Information Systems at Boehringer
Ingelheim Pharmaceuticals, Inc.
"We are delighted that
Boehringer Ingelheim has selected Veeva as their CRM provider globally.
Boehringer Ingelheim's focus on speed, innovation and meeting the needs of the
local markets is consistent with Veeva's philosophy. Combined with Boehringer
Ingelheim's strong global leadership team this creates an amazing force for
both execution and competitive differentiation in the industry," concluded Dan
Goldsmith, general manager, Europe, Veeva
Systems.
For more information visit
www.veevasystems.com.
About Veeva Systems
Veeva Systems is the leader in cloud-based business solutions for the
global life sciences industry. Committed to innovation, product excellence and
customer success, Veeva has over 150 customers, ranging from the world's
largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva
is a privately held company headquartered in the San Francisco Bay Area, with
offices in Philadelphia, Barcelona,
Paris, Beijing,
Shanghai and Tokyo.